ENTRADA THERAPEUTICS, INC. — Cash Flow Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Buybacks vs Stock-Based Comp
Cash Flow
Cash Flow by Activity
Operating Cash Flow↓-50.9% -$13M
$-39M
Free Cash Flow↓-100.7% -$39M
$-275K
Investing Cash Flow↓-45.4% -$24M
$29M
Financing Cash Flow↓-86.3% -$1M
$192K
Capex↓-73.7% -$771K
$275K
Stock-Based Comp↓-7.3% -$342K
$4M
D&A↓-10.7% -$106K
$886K
SBC Allocated Expense↓-7.3% -$342K
$4M